Results of an intervention in an academic internal medicine clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change

Journal of Managed Care Pharmacy

Volumn 15, Issue 4, 2009, Pages 344-350

  Ramser, Kristie L ^a,d   Sprabery, Laura R ^b   Hamann, Gale L ^b   George, Christa M ^a   Will, Aaron ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c DUKE UNIVERSITY HOSPITAL   (United States)

^d Regional Medical Center Memphis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; RANITIDINE;

ARTICLE; BARRETT ESOPHAGUS; CLINICAL PROTOCOL; COLITIS; CYSTIC FIBROSIS; DIVERTICULITIS; DRUG APPROVAL; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; DUODENUM ULCER; ESOPHAGITIS; ESOPHAGUS DISEASE; ESOPHAGUS STRICTURE; FOLLOW UP; GASTRITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL HEMORRHAGE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTIPLE ENDOCRINE ADENOMATOSIS; OUTPATIENT; PRESCRIPTION; REFLUX ESOPHAGITIS; RETROSPECTIVE STUDY; SCHATZKI RING; STOMACH DISEASE; STOMACH PARESIS; STOMACH ULCER; TELECONSULTATION; TREATMENT FAILURE; TREATMENT INDICATION; ZOLLINGER ELLISON SYNDROME;

EID: 66749116638     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2009.15.4.344     Document Type: Article

References (26)

1. Top 200 Brand-Name Drugs by Units in 2007. Drug Topics. February 18, 2008. Available at: http://drugtopics.modernmedicine.com/drugtopics/data/ articlestandard//drugtopics/072008/491207/article.pdf. Accessed April 16, 2009.
2. AstraZeneca LP. Nexium® [prescribing information). 2007. Available at: http://wwwl.astrazeneca-us.com/pi/Nexium.pdf. Accessed January 16, 2009.
3. Takeda Pharmaceuticals North America, Inc. Prevacid® [prescribing information]. Available at: http://www.prevacid.com/pi.aspx. Accessed April 16, 2009.
4. Wyeth Pharmaceuticals, Inc.Protonix [prescribing information]. June 2007. Available at: http://www.wyeth.com/content/showlabeling.asp?id=135. Accessed April 16, 2009.
5. AstraZeneca LP. Omeprazole [prescribing information]. Available at: http://wwwl.astrazeneca-us.com/pi/Prilosec.pdf. Accessed April 16, 2009.
6. AstraZeneca and Proctor and Gamble, Inc. Prilosec OTC [product monograph]. January 2004. Available at: http://www.prilosecotc.com/hcp/hcp- strongcompliance.jsp. Accessed April 16, 2009.
7. Shaheen NJ, Hansen RA, Morgan DR, et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol. 2006;101(9):2128-2138 (Pubitemid 44337640)
8. Top 200 Generic Drugs by Units in 2007. Drug Topics, February 18, 2008. Available at: http://drugtopics.modernmedicine.com/drugtopics/data/article- standard//drugtopics/072008/491181/article.pdf. Accessed April 16, 2009.
9. Top 200 Over-the-Counter and Health and Beauty Care Brands in 2007. Drug Topics, February 25, 2008. Available at: http://drugtopics.modernmedicine.com/ drugtopics/data/articlestandard//drugtopics/082008/492702/article.pdf. Accessed April 16, 2009.
10. Naunton M, Peterson GM, Bleasel MD. Overuse of proton pump inhibitors. J Clin Pharm Ther. 2000;25(5):333-340
11. Pohland CJ, Scavnicky SA, Lasky SS, Good CB. Lansoprazole overutilization: methods for step-down therapy. Am J Manag Care. 2003;9(5):353-58. (Pubitemid 36612116)
12. Behar J, Brand DL, Brown FC, et al. Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial. Gastroenterology. 1978;74(2):441-448 (Pubitemid 8276596)
13. Sontag S, Robinson M, McCallum RW, Barwick KW, Nardi R. Ranitidine therapy for gastroesophageal reflux disease: results of a large double-blind trial. Arch Intern Med. 1987;147(8):1485-1491 (Pubitemid 17127940)
14. Euler AR, Murdock RH, Wilson TH, Silver MT, Parker SE, Powers L. Ranitidine is effective therapy for erosive esophagitis. Am J Gastroenterol. 1993;88(4):520-524 (Pubitemid 23106585)
15. Khan M, Santana J, Donnellan C, Preston C, Moayyedi P. Medical treatments in the short term management of reflux oesophagitis. Cochrane Database Syst Rev. 2007; Apr 18 (2): CD003244.
16. Prices obtained from: http://www.drugstore.com/. Accessed October 15, 2008.
17. Ip S, Bonis P, Tatsioni A, et al. Comparative effectiveness of management strategies for gastroesophageal reflux disease. Comparative effectiveness review no. 1. (Prepared by Tufts-New England Medical Center Evidence-based Practice Center under Contract No. 290-02-0022.) Rockville, MD: Agency for Healthcare Research and Quality; December 2005. Available at: http://effectivehealthcare.ahrq.gov/repFiles/GERD%20Final%20Report.pdf. Accessed April 17, 2009
18. West DS, Johnson JT, Hong SH. A 30-month evaluation of the effects on the cost and utilization of proton pump inhibitors from adding omeprazole OTC to drug benefit coverage in a state employee health plan. J Manag Care Pharm. 2006;12(1):25-32. Available at: http://www.amcp.org/data/jmcp/research-25-32. pdf. (Pubitemid 47400553)
19. Anonymous. Treatment of gastroesophageal reflux disease in a managed care environment. Based on a presentation by Kevin Ashby, MD. Am J Manag Care. 2000;6(suppl 9):S480-83.
20. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005;100(1):190-200. (Pubitemid 41623288)
21. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1999;94(6):1434-1442
22. Metz DC, Inadomi JM, Howden CW, van Zanten SJ, Bytzer P. On-demand therapy for gastroesophageal reflux disease. Am J Gastroenterol. 2007;102(3):642-653 (Pubitemid 46328170)
23. Sridhar S. Huang J, O'Brien BJ, Hunt RH. Clinical economics review: cost-effectiveness of treatment alternatives for gastro-oesophageal reflux. Aliment Pharmacol Ther. 1996;10(6):865-873 (Pubitemid 26412913)
24. Gerson LB, Robbins AS, Garber A, Hornberger J, Triadafilopoulos G. A cost-effectiveness analysis of prescribing stategies in the management of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 2000;95(2):395-407.
25. Piterman L, Nelson M, Dent J. Gastro-oesophageal reflux disease: current concepts in management. Aust Fam Physician. 2004;33(12):987-991
26. Inadomi JM, Jamal R, Murata GH, et al. Step-down management of gastroesophageal reflux disease. Gastroenterology. 2001;121(5):1095-1100 (Pubitemid 33022089)